SEAN WEBSTER PA-C: Open Payments
NPI 1063759215 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 117 payments from 24 companies in 2025. Trend: 2023 $1,861 · 2024 $1,620 · 2025 $1,933
Food & beverage: $1,933
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $416 |
| Lilly USA, LLC | 18 | $220 |
| AstraZeneca Pharmaceuticals LP | 7 | $201 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $166 |
| Amgen Inc. | 15 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $99 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Grifols USA, LLC | 4 | $81 |
| Novo Nordisk Inc | 4 | $67 |
| PFIZER INC. | 4 | $64 |
Products named: VRAYLAR, MOUNJARO, JARDIANCE, BREZTRI, QULIPTA, CAPLYTA, OTEZLA, Prolastin-C Liquid.
Industry payments across UT — which companies pay providers there.
